These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 35225130)
21. The Psychological Experience of COVID-19 Vaccination and Its Impact on the Willingness to Receive Booster Vaccines among the Chinese Population: Evidence from a National Cross-Sectional Study. Miao Y; Li Y; Zhang W; Wu J; Gu J; Wang M; Wei W; Ye B; Miao C; Tarimo CS; Dong W Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564859 [TBL] [Abstract][Full Text] [Related]
22. Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL). Meacham PJ; Williams AM; Strawderman M; Baran AM; Archibald WJ; Wallace DS; Tschernia NP; Burack WR; Barr PM; Zent CS Leuk Lymphoma; 2020 Jul; 61(7):1636-1644. PubMed ID: 32175786 [TBL] [Abstract][Full Text] [Related]
23. Seroconversion after COVID-19 vaccination and heart transplant recipients: Correspondence. Sriwijitalai W; Wiwanitkit V Transpl Infect Dis; 2022 Dec; 24(6):e13962. PubMed ID: 36169215 [No Abstract] [Full Text] [Related]
24. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664 [TBL] [Abstract][Full Text] [Related]
25. Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience. Yigit M; Ozkaya-Parlakay A; Cosgun Y; Ince YE; Bulut YE; Senel E J Med Virol; 2022 Jan; 94(1):287-290. PubMed ID: 34487373 [TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial. Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Chen P; Söderdahl G; Österborg A; Smith CIE; Wullimann D; Vesterbacka J; Lindgren G; Blixt L; Friman G; Wahren-Borgström E; Nordlander A; Gomez AC; Akber M; Valentini D; Norlin AC; Thalme A; Bogdanovic G; Muschiol S; Nilsson P; Hober S; Loré K; Chen MS; Buggert M; Ljunggren HG; Ljungman P; Aleman S; EBioMedicine; 2021 Dec; 74():103705. PubMed ID: 34861491 [TBL] [Abstract][Full Text] [Related]
27. Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine. Cancer Discov; 2021 Sep; 11(9):2122. PubMed ID: 34272229 [TBL] [Abstract][Full Text] [Related]
37. A booster with SARS-CoV-2 vaccines: protection against Omicron infection. Hu Y; Sun Q Signal Transduct Target Ther; 2022 Apr; 7(1):115. PubMed ID: 35383164 [No Abstract] [Full Text] [Related]